[go: up one dir, main page]

WO2008006105A3 - Marqueurs génétiques dans le gène du récepteur de la tachykinine nk1 (tacr1) correspondant à des troubles asthmatiques - Google Patents

Marqueurs génétiques dans le gène du récepteur de la tachykinine nk1 (tacr1) correspondant à des troubles asthmatiques Download PDF

Info

Publication number
WO2008006105A3
WO2008006105A3 PCT/US2007/073066 US2007073066W WO2008006105A3 WO 2008006105 A3 WO2008006105 A3 WO 2008006105A3 US 2007073066 W US2007073066 W US 2007073066W WO 2008006105 A3 WO2008006105 A3 WO 2008006105A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
asthma
tacr1
tachykinin
correlate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/073066
Other languages
English (en)
Other versions
WO2008006105A9 (fr
WO2008006105A2 (fr
Inventor
Eva Halapi
Hakon Hakonarson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decode Genetics ehf
Original Assignee
Decode Genetics ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decode Genetics ehf filed Critical Decode Genetics ehf
Publication of WO2008006105A2 publication Critical patent/WO2008006105A2/fr
Publication of WO2008006105A9 publication Critical patent/WO2008006105A9/fr
Publication of WO2008006105A3 publication Critical patent/WO2008006105A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Les polymorphismes du gène TACR1 faisant l'objet de la présente invention se révèlent, par analyse associative, analogues à un gène de sensibilité à l'asthme. L'invention concerne également des procédés permettant de diagnostiquer une sensibilité à l'asthme, une sensibilité réduite à l'asthme et une protection contre l'asthme, de même que des procédés de traitement de l'asthme.
PCT/US2007/073066 2006-07-07 2007-07-09 Marqueurs génétiques dans le gène du récepteur de la tachykinine nk1 (tacr1) correspondant à des troubles asthmatiques Ceased WO2008006105A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81919806P 2006-07-07 2006-07-07
US60/819,198 2006-07-07

Publications (3)

Publication Number Publication Date
WO2008006105A2 WO2008006105A2 (fr) 2008-01-10
WO2008006105A9 WO2008006105A9 (fr) 2008-04-03
WO2008006105A3 true WO2008006105A3 (fr) 2008-08-14

Family

ID=38670544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/073066 Ceased WO2008006105A2 (fr) 2006-07-07 2007-07-09 Marqueurs génétiques dans le gène du récepteur de la tachykinine nk1 (tacr1) correspondant à des troubles asthmatiques

Country Status (1)

Country Link
WO (1) WO2008006105A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016399A2 (fr) * 2000-08-25 2002-02-28 Genaissance Pharmaceuticals, Inc. Haplotypes du gene tacr1
EP1262565A2 (fr) * 2001-05-25 2002-12-04 Pfizer Products Inc. Polymorphismes génétiques dans le gène humain du récepteur de la neurokinine 1 et leurs usages dans diagnostic et traitement de maladies
JP2003259875A (ja) * 2002-03-08 2003-09-16 Japan Science & Technology Corp ヒト遺伝子の一塩基多型（４）
WO2005100986A1 (fr) * 2004-04-15 2005-10-27 Bayer Healthcare Ag Diagnostics et methodes therapeutiques pour des maladies associees au recepteur de la tachykinine (tacr1)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016399A2 (fr) * 2000-08-25 2002-02-28 Genaissance Pharmaceuticals, Inc. Haplotypes du gene tacr1
EP1262565A2 (fr) * 2001-05-25 2002-12-04 Pfizer Products Inc. Polymorphismes génétiques dans le gène humain du récepteur de la neurokinine 1 et leurs usages dans diagnostic et traitement de maladies
JP2003259875A (ja) * 2002-03-08 2003-09-16 Japan Science & Technology Corp ヒト遺伝子の一塩基多型（４）
WO2005100986A1 (fr) * 2004-04-15 2005-10-27 Bayer Healthcare Ag Diagnostics et methodes therapeutiques pour des maladies associees au recepteur de la tachykinine (tacr1)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ADCOCK I M ET AL: "Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids.", JOURNAL OF MOLECULAR ENDOCRINOLOGY AUG 1993, vol. 11, no. 1, August 1993 (1993-08-01), pages 1 - 7, XP009092353, ISSN: 0952-5041 *
ALMEIDA T A ET AL: "Tachykinins and tachykinin receptors: structure and activity relationships.", CURRENT MEDICINAL CHEMISTRY AUG 2004, vol. 11, no. 15, August 2004 (2004-08-01), pages 2045 - 2081, XP002459773, ISSN: 0929-8673 *
DATABASE EMBL [online] ebi; 6 May 2004 (2004-05-06), "human SNP", XP002479802, retrieved from EMBL Database accession no. ADK91051 *
DATABASE SNP [online] nih; 17 February 2004 (2004-02-17), XP002459774, retrieved from NCBI.NLM.NIH.GOV Database accession no. ss16811250 *

Also Published As

Publication number Publication date
WO2008006105A9 (fr) 2008-04-03
WO2008006105A2 (fr) 2008-01-10

Similar Documents

Publication Publication Date Title
MX2007015848A (es) Variantes geneticas en el gen tcf7l2 como marcadores de diagnostico para el riesgo de diabetes mellitus tipo 2.
WO2010031056A3 (fr) Procédés et compositions pour moduler l'activité ire1, src, et abl
WO2007027509A3 (fr) Evaluation et traitement de la sclerodermie
WO2008154695A8 (fr) Procédé permettant d'améliorer la résistance à un stress de plantes et de leurs matériaux
WO2008061213A3 (fr) Variations génétiques associées à des tumeurs
WO2011153553A3 (fr) Méthodes et compositions pour l'inhibition de kinases
WO2009108860A8 (fr) Procédés et compositions à base de micro-arn permettant de diagnostiquer, de pronostiquer et de traiter des troubles liés à la prostate
WO2008028044A9 (fr) Marqueurs et procédés pour évaluer et traiter la recto-colite hémorragique et des troubles associés utilisant un panel de 66 gènes
WO2009006297A3 (fr) Procédés de modification du génome d'une cellule de plante monocotylédone
WO2009086215A3 (fr) Analyse de voies de phénotypes de culture de cellules et utilisations de celle-ci
GB2476188B (en) Evaluating genetic disorders
GB2477868A (en) Methods and systems for incorporating multiple environmental and genetic risk factors
WO2007107789A3 (fr) Traitement des maladies du snc
WO2007025177A3 (fr) Neurogenese par modulation du recepteur muscarinique
ZA200902814B (en) Compositions and methods for diagnosing, treating, and preventing prostate conditions
SI1935331T1 (sl) Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode
WO2009059321A3 (fr) Analyse de lieu de rca pour estimer la sensibilité à l'amd et au mpgnii
WO2008117314A3 (fr) Variants génétiques du chr2 et chr16 utilisés comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein
WO2011044458A8 (fr) Compositions et méthodes de diagnostic de maladies et de troubles associés au génome
WO2005094370A3 (fr) Compositions de complexe d'oligonucleotides et procedes d'utilisation de celles-ci comme outils de modification de genes
WO2007124312A3 (fr) Molécules polynucléotidiques isolées correspondant aux allèles mutants et de type sauvage du gène d9 du maïs et leurs procédés d'utilisation
WO2008067423A3 (fr) Procédé d'amélioration de l'introduction d'adn dans des cellules bactériennes
WO2008136996A3 (fr) Polymorphismes géniques affectant les troubles associés à l'ace et utilisations
WO2011081928A3 (fr) Compositions et procédés pour modifier l'activité de la cocaïne estérase
GB2465814B (en) Method,composition and device for the treatment of enzymes and saccharides disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07799409

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07799409

Country of ref document: EP

Kind code of ref document: A2